Skip to main content
. 2010 Apr 5;54(6):2507–2516. doi: 10.1128/AAC.00250-10

TABLE 2.

In vitro antileishmanial activities of AIAs against intracellular L. donovani clinical isolates

Compoundb IC50 (μM)a vs L. donovani:
AG83-S MC4-R MC8-R
DB745 0.13 ± 0.01 0.15 ± 0.02 0.16 ± 0.03
DB766 0.090 ± 0.013 0.076 ± 0.005 0.064 ± 0.010
Sb(V) 9.0 ± 0.5 44 ± 3 40 ± 5
Sb(III) 6.2 ± 1.8 32 ± 5 26 ± 5
a

Mean ± standard deviation of at least three independent determinations.

b

Sb(V), sodium stibogluconate; Sb(III), sodium antimony tartrate.